Company / Current Liabilities per Share
Harvard Apparatus Regenerative Technology, Inc. Current Liabilities per Share History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.10
FY2025
5-year range
$0.07 / $0.52
FY2021-FY2025
Trend
+31.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share returned to growth in FY2025 after 2 years of decline, reaching $0.10.
Based on SEC 10-K filings.
0.10 in FY2025 with a 10-year CAGR of +1.5%.
Increased from $0.08 to $0.10 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +0.8%
- 10-Year CAGR
- +1.5%
Key checks
Key Insights
- In FY2025, current liabilities per share increased 31.6% year-over-year.
- Peak current liabilities per share was recorded in FY2017.
- Lowest current liabilities per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -41.12 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.10 | +31.6% |
| FY2024 | $0.07 | -7.9% |
| FY2023 | $0.08 | -84.6% |
| FY2021 | $0.52 | +455.7% |
| FY2020 | $0.09 | -35.4% |
| FY2019 | $0.14 | -45.6% |
| FY2018 | $0.26 | -86.1% |
| FY2017 | $1.90 | +862.8% |
| FY2016 | $0.20 | +136.6% |
| FY2015 | $0.08 | -9.2% |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026